FIELD: medicine.
SUBSTANCE: invention refers to biotechnology, in particular to tumour-specific promoters, and can be used in the anti-cancer therapy. There are constructed the broad-spectrum tumour-specific promoters providing the therapeutic gene expression inside a cancer cell. The invention also involves expression cassettes, expression vectors, pharmaceutical compositions, methods of treating cancer and using the expression cassettes and vectors.
EFFECT: promoters of the present invention provide a high expression level of the operatively linked therapeutic gene in the cancer cells of different origin, wherein the normal cell expression is absent or low.
29 cl, 19 dwg, 4 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
MULTI-PURPOSE PROMOTER, EXPRESSION VECTOR, AND METHOD OF SELECTIVE KILLING CANCER CELLS WITH THEIR USE | 2012 |
|
RU2476596C1 |
UNIVERSAL PROMOTER FOR EXPRESSION OF THERAPEUTIC GENES IN MAMMALIAN CELLS | 2013 |
|
RU2551784C1 |
GENE THERAPY PREPARATION FCU1-BSFM/PP FOR TREATING SOLID TUMOURS | 2023 |
|
RU2824977C1 |
PHARMACOLOGICAL COMBINATION OF POLYCATIONIC CARRIER PEG-PEI-TAT WITH INCLUDED IN IT PLASMID CARRYING THERAPEUTIC GENES HSVtk AND GM-CSF FOR GENE THERAPY OF TUMOROUS DISEASES | 2013 |
|
RU2575077C2 |
HISTONES AND BIODEGRADABLE LIPIDES AS MEANS FOR NUCLEIC ACIDS DELIVERY TO EUKARYOTIC CELLS | 2015 |
|
RU2637371C2 |
DRUG COMBINATION FOR GENE-IMMUNE THERAPY | 2022 |
|
RU2792683C1 |
IMMORTALISED CELL LINE OF BIRDS | 2008 |
|
RU2475536C2 |
METHOD FOR DETECTION OF TUMOUR GROWTH Pdcd4 SUPPRESSOR SUPPRESSION INHIBITORS IN TUMOUR CELLS AND pLucPdcd4 GENETIC CONSTRUCT FOR ITS IMPLEMENTATION | 2016 |
|
RU2640909C1 |
PROMOTER FOR TISSUE-SPECIFIC GENE EXPRESSION IN TERMINAL MAMMAL TISSUES | 2010 |
|
RU2459870C2 |
ALLOGENEIC ANTITUMOR THERAPEUTIC MEDICATION | 2004 |
|
RU2354694C2 |
Authors
Dates
2015-01-27—Published
2013-04-02—Filed